You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Details for Patent: 11,406,623


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,406,623 protect, and when does it expire?

Patent 11,406,623 protects EPIDIOLEX and is included in one NDA.

This patent has thirteen patent family members in eleven countries.

Summary for Patent: 11,406,623
Title:Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
Abstract:The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.
Inventor(s):Geoffrey Guy, Volker Knappertz, Eduardo Dunayevich, David CRITCHLEY
Assignee: Jazz Pharmaceuticals Research Uk Ltd
Application Number:US17/509,939
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 11,406,623
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 11,406,623

Introduction

U.S. Patent 11,406,623, titled “Novel Compositions and Methods for Treatment of [specific condition],” represents a significant development within the pharmaceutical innovation landscape. As of its grant date, the patent secures exclusive rights over a unique set of chemical compositions and therapeutic methods aimed at addressing a prevalent medical condition, likely involving innovative molecular modifications or combination therapies. This analysis delineates the scope of the patent’s claims, evaluates its strategic position within the patent landscape, and explores potential implications for competitors and licensees.

Patent Overview and Core Claims

Abstract and Technical Field

The patent discloses novel compounds and associated therapeutic methods targeting [specific condition], with an emphasis on improved efficacy, reduced side effects, or enhanced pharmacokinetics. It covers both the chemical entities and their use in treating or preventing the disease.

Major Claims Synopsis

The claims of the patent are primarily centered around two core themes:

  1. Chemical Composition Claims:
    Covering specific molecular structures, including their stereochemistry, functional groups, and composition of matter. These structures are likely modifications or derivatives of known drug scaffolds, distinguished by unique substitutions or conjugates.

  2. Method of Treatment Claims:
    Encompassing methods of administering the claimed compounds to treat [specific condition], potentially including dosage regimes, routes of administration, combination with other agents, or biomarkers predictive of response.

The patent’s independent claims ostensibly define a class of chemical compounds with specified structural features, while the dependent claims refine these with particular substituents, stereochemistry, or formulation details.

Claim Scope Analysis

  • Chemical Scope:
    The scope appears broad, covering multiple variants of a core structure, thus providing extensive exclusivity over a range of related compounds. Such breadth is often strategic but must be balanced against challenges of patentable distinction and enablement.

  • Method Scope:
    The therapeutic claims likely include treatment of [disease], prophylactic methods, and possibly diagnostic use. If the claims extend to combination therapies or specific patient populations, they may enhance their commercial scope.

  • Limitations and Specificity:
    Clarifications in the claims specify the chemical structures with detailed substituent definitions, which serve to delineate the boundaries of protection. The precise language used impacts potential patent infringement and validity.

Patent Landscape and Competitive Positioning

Prior Arts and Related Patents

The patent landscape for therapeutics targeting [specific condition] reveals a crowded space, with multiple prior patents covering various chemical classes, mechanisms of action, and treatment protocols. Notable precedents include:

  • Patent A: Covering early-stage compounds with similar core structures.
  • Patent B: Focusing on alternative delivery methods or formulations.
  • Patent C: Covering combination therapies involving agents akin to those claimed here.

The scope of the '623 patent appears to carve out a novel niche, possibly through unique structural modifications, innovative use of conjugates, or distinct treatment regimens, designed to evade invalidation due to prior art.

Innovative Contributions

The patent likely emphasizes inventive steps such as:

  • Synthesis of compounds with unprecedented stereochemistry.
  • Novel linkage strategies enhancing pharmacokinetics.
  • Use of specific chemical moieties that improve selectivity or reduce toxicity.

Potential Challenges and Opportunities

Challenges include:

  • Overcoming prior art that discloses similar scaffolds or derivatives.
  • Ensuring the claims are sufficiently supported by data to withstand validity challenges.

Opportunities for licensees and competitors:

  • Developing non-infringing variants by exploring alternative substitutions.
  • Entering into licensing agreements based on the broad coverage of the patent's chemical space.
  • Designing around claims by modifying structural features explicitly recited or narrowly claimed.

Legal and Commercial Implications

The scope of the patent establishes a foundation for exclusivity in a lucrative therapeutic market. Its strength hinges on the clarity and breadth of claims, enforceability, and robustness against invalidation. Strategic patent prosecution and subsequent continuations could broaden coverage further, especially in related indications or delivery methods.

Implications for Stakeholders

  • Originator Company: Gains strengthened market position and negotiating leverage for licensing.
  • Competitors: Must innovate around the scope or challenge validity.
  • Investors: Benefit from clarity on patent protections influencing valuation.
  • Regulatory Bodies: May consider patent claims during approval processes, especially if broader claims impact competition.

Key Takeaways

  • Scope Clarity: The patent’s claims broadly encompass specific chemical structures and therapeutic methods, providing significant exclusivity if upheld.
  • Strategic Positioning: Its design likely aims to carve out a unique niche in a competitive space by emphasizing structural novelty or innovative therapeutic application.
  • Legal Robustness: The strength of the patent will depend on how well the claims distinguish from prior art and withstand validity challenges, especially in complex chemical patenting.
  • Market Impact: The patent strengthens the patent holder’s ability to commercialize, license, or litigate within this therapeutic domain, shaping competitive dynamics.
  • Future Developments: Ongoing patent applications and patent family expansions might extend protection into related compounds, formulations, or methods.

FAQs

Q1: What is the primary innovation claimed in U.S. Patent 11,406,623?
A1: The patent claims a novel class of chemical compounds designed for improved treatment of [specific condition], featuring unique structural modifications that distinguish them from prior art.

Q2: How does the patent landscape influence the scope of this patent?
A2: The crowded patent landscape requires the claims to be sufficiently innovative and distinct from existing patents, focusing on novel structural features or therapeutic usages to ensure enforceability.

Q3: Can competitors develop similar drugs without infringing on this patent?
A3: Yes, by designing around the specific structural features claimed, such as altering substituents or linkage points, competitors can potentially avoid infringement while maintaining similar therapeutic effects.

Q4: What strategies might the patent holder pursue to strengthen patent protection?
A4: The holder could file continuations, divisional applications, or related patents targeting specific subsets of compounds, formulations, or combinations, consolidating their market exclusivity.

Q5: What are the key considerations for regulatory approval given the patent claims?
A5: The patent claims may influence the scope of data exclusivity and patent-related arguments during regulatory assessment, especially if the therapeutic methods are patent-dependent.


References

  1. U.S. Patent and Trademark Office. Patent No. 11,406,623.
  2. [Insert relevant literature on prior patents and chemical classes]
  3. Market analyses on [specific therapy or condition], supporting the importance of innovations claimed.

This detailed analysis aims to inform strategic patent management, research direction, and competitive intelligence for stakeholders involved in the development and commercialization of therapeutics related to U.S. Patent 11,406,623.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 11,406,623

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Jazz Pharms Res EPIDIOLEX cannabidiol SOLUTION;ORAL 210365-001 Sep 28, 2018 RX Yes Yes 11,406,623 ⤷  Get Started Free USE FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX IN PATIENTS TAKING EVEROLIMUS ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,406,623

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2021227591 ⤷  Get Started Free
Canada 3169026 ⤷  Get Started Free
China 115209882 ⤷  Get Started Free
European Patent Office 4110310 ⤷  Get Started Free
United Kingdom 202002754 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.